BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 11296225)

  • 1. mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module.
    Dodge KL; Khouangsathiene S; Kapiloff MS; Mouton R; Hill EV; Houslay MD; Langeberg LK; Scott JD
    EMBO J; 2001 Apr; 20(8):1921-30. PubMed ID: 11296225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways.
    Dodge-Kafka KL; Soughayer J; Pare GC; Carlisle Michel JJ; Langeberg LK; Kapiloff MS; Scott JD
    Nature; 2005 Sep; 437(7058):574-8. PubMed ID: 16177794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKA-phosphorylation of PDE4D3 facilitates recruitment of the mAKAP signalling complex.
    Carlisle Michel JJ; Dodge KL; Wong W; Mayer NC; Langeberg LK; Scott JD
    Biochem J; 2004 Aug; 381(Pt 3):587-92. PubMed ID: 15182229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cAMP-stimulated protein phosphatase 2A activity associated with muscle A kinase-anchoring protein (mAKAP) signaling complexes inhibits the phosphorylation and activity of the cAMP-specific phosphodiesterase PDE4D3.
    Dodge-Kafka KL; Bauman A; Mayer N; Henson E; Heredia L; Ahn J; McAvoy T; Nairn AC; Kapiloff MS
    J Biol Chem; 2010 Apr; 285(15):11078-86. PubMed ID: 20106966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase A and phosphodiesterase-4D3 binding to coding polymorphisms of cardiac muscle anchoring protein (mAKAP).
    Rababa'h A; Craft JW; Wijaya CS; Atrooz F; Fan Q; Singh S; Guillory AN; Katsonis P; Lichtarge O; McConnell BK
    J Mol Biol; 2013 Sep; 425(18):3277-88. PubMed ID: 23806656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi.
    Baillie GS; Sood A; McPhee I; Gall I; Perry SJ; Lefkowitz RJ; Houslay MD
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):940-5. PubMed ID: 12552097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mAKAP signaling complex: integration of cAMP, calcium, and MAP kinase signaling pathways.
    Dodge-Kafka KL; Kapiloff MS
    Eur J Cell Biol; 2006 Jul; 85(7):593-602. PubMed ID: 16460834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compartmentalization of cAMP-dependent signaling by phosphodiesterase-4D is involved in the regulation of vasopressin-mediated water reabsorption in renal principal cells.
    Stefan E; Wiesner B; Baillie GS; Mollajew R; Henn V; Lorenz D; Furkert J; Santamaria K; Nedvetsky P; Hundsrucker C; Beyermann M; Krause E; Pohl P; Gall I; MacIntyre AN; Bachmann S; Houslay MD; Rosenthal W; Klussmann E
    J Am Soc Nephrol; 2007 Jan; 18(1):199-212. PubMed ID: 17135396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In resting COS1 cells a dominant negative approach shows that specific, anchored PDE4 cAMP phosphodiesterase isoforms gate the activation, by basal cyclic AMP production, of AKAP-tethered protein kinase A type II located in the centrosomal region.
    McCahill A; McSorley T; Huston E; Hill EV; Lynch MJ; Gall I; Keryer G; Lygren B; Tasken K; van Heeke G; Houslay MD
    Cell Signal; 2005 Sep; 17(9):1158-73. PubMed ID: 15905070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human muscle-specific A-kinase anchoring protein polymorphisms modulate the susceptibility to cardiovascular diseases by altering cAMP/PKA signaling.
    Suryavanshi SV; Jadhav SM; Anderson KL; Katsonis P; Lichtarge O; McConnell BK
    Am J Physiol Heart Circ Physiol; 2018 Jul; 315(1):H109-H121. PubMed ID: 29600899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKAP signaling complexes: getting to the heart of the matter.
    McConnachie G; Langeberg LK; Scott JD
    Trends Mol Med; 2006 Jul; 12(7):317-23. PubMed ID: 16809066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mAKAP and the ryanodine receptor are part of a multi-component signaling complex on the cardiomyocyte nuclear envelope.
    Kapiloff MS; Jackson N; Airhart N
    J Cell Sci; 2001 Sep; 114(Pt 17):3167-76. PubMed ID: 11590243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of type 4 cAMP-phosphodiesterase in the myogenic differentiation of L6 cells.
    Naro F; Sette C; Vicini E; De Arcangelis V; Grange M; Conti M; Lagarde M; Molinaro M; Adamo S; Némoz G
    Mol Biol Cell; 1999 Dec; 10(12):4355-67. PubMed ID: 10588663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An anchored PKA and PDE4 complex regulates subplasmalemmal cAMP dynamics.
    Willoughby D; Wong W; Schaack J; Scott JD; Cooper DM
    EMBO J; 2006 May; 25(10):2051-61. PubMed ID: 16642035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation.
    Sette C; Conti M
    J Biol Chem; 1996 Jul; 271(28):16526-34. PubMed ID: 8663227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterase 4D and protein kinase a type II constitute a signaling unit in the centrosomal area.
    Taskén KA; Collas P; Kemmner WA; Witczak O; Conti M; Taskén K
    J Biol Chem; 2001 Jun; 276(25):21999-2002. PubMed ID: 11285255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cAMP-specific phosphodiesterase PDE4D3 is regulated by phosphatidic acid binding. Consequences for cAMP signaling pathway and characterization of a phosphatidic acid binding site.
    Grange M; Sette C; Cuomo M; Conti M; Lagarde M; Prigent AF; Némoz G
    J Biol Chem; 2000 Oct; 275(43):33379-87. PubMed ID: 10938092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo selective binding of (R)-[11C]rolipram to phosphodiesterase-4 provides the basis for studying intracellular cAMP signaling in the myocardium and other peripheral tissues.
    Kenk M; Greene M; Thackeray J; deKemp RA; Lortie M; Thorn S; Beanlands RS; DaSilva JN
    Nucl Med Biol; 2007 Jan; 34(1):71-7. PubMed ID: 17210463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579.
    Hoffmann R; Baillie GS; MacKenzie SJ; Yarwood SJ; Houslay MD
    EMBO J; 1999 Feb; 18(4):893-903. PubMed ID: 10022832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short term feedback regulation of cAMP in FRTL-5 thyroid cells. Role of PDE4D3 phosphodiesterase activation.
    Oki N; Takahashi SI; Hidaka H; Conti M
    J Biol Chem; 2000 Apr; 275(15):10831-7. PubMed ID: 10753877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.